Medication risk does not rise only because an older adult takes more pills. The illnesses prompting those prescriptions, changes in kidney and liver function, and fragmented care across specialists can combine into a much more complicated safety problem. A recent study found a steep relationship between the number of chronic conditions and the odds of reporting an adverse drug reaction.
The risk rose with each additional chronic condition
The analysis used information from 4,478 community-dwelling older adults and grouped participants by both the number and type of chronic diseases. Researchers then adjusted for age, sex, education, exercise and several other characteristics.
Compared with participants who had one or no chronic disease, those with two conditions had 1.87 times the adjusted odds of a self-reported adverse reaction. The published study found the odds rose to 2.63 with three conditions, 3.15 with four, and 6.22 with five or more. Arthritis or spinal disease, depression and cardio-cerebrovascular disease showed particularly strong associations.
Those figures describe relative odds within the study, not the probability that a particular patient will be harmed. The cross-sectional design also cannot prove that the diseases themselves caused each reaction. Still, the stepwise pattern identifies people who may benefit from more deliberate medication review.
Multiple illnesses create more than a pill-count problem
Polypharmacy is often defined as using five or more medicines, but raw counts can hide important differences. Five necessary, well-coordinated prescriptions may be safer than three drugs whose effects overlap or whose doses are not adjusted for kidney function.
Chronic conditions can change how the body absorbs, distributes and clears medicine. Heart failure may alter circulation, kidney disease can slow removal of some drugs, and liver disease can affect metabolism. Symptoms of one illness may also resemble side effects from a treatment, making the cause difficult to identify.
A complete list is the foundation of a useful review
The National Institute on Aging recommends keeping an updated record of prescriptions, nonprescription medicines, vitamins and supplements. Its guidance on the safe use of medicines by older adults also stresses sharing that list with every clinician and pharmacist involved in care.
The list should include doses, timing and the reason each product is used. Eye drops, sleep aids, pain relievers, antacids and herbal products count because they can still interact with prescriptions. A medication review is more useful when it asks whether each item still has a clear purpose, whether the dose fits current organ function, and whether two products duplicate the same effect.
Interactions can appear as ordinary aging
Dizziness, confusion, falls, constipation, appetite changes and unusual fatigue may be blamed on age or a chronic disease. They can also signal a drug effect, an interaction or a dose that has become too strong after weight loss or declining kidney function.
The Food and Drug Administration’s consumer guidance on drug interactions advises checking active ingredients and asking about food, alcohol and other medicines. One product can change how another is absorbed or broken down, while two medicines may intensify the same side effect.
Safer prescribing is coordinated, not abrupt
The study does not support stopping medicines without guidance. Suddenly discontinuing blood-pressure drugs, steroids, seizure medicines, antidepressants or other therapies can cause withdrawal or allow a controlled disease to worsen.
Instead, clinicians can use a structured process often called medication reconciliation or deprescribing. The goal is to confirm the list, identify the highest-risk combinations, simplify schedules when possible, taper medicines that no longer provide enough benefit, and monitor what happens after a change.
Transitions between hospital, rehabilitation and home are especially vulnerable points. A medicine may be added for a short inpatient problem and remain on the list after the reason disappears. Duplicate brand and generic names can also survive when records from separate systems do not reconcile cleanly.
Pharmacists can check interaction databases and refill patterns, but clinical judgment remains necessary. A computer may flag a theoretical interaction that is manageable with monitoring while missing that dizziness has made a particular regimen dangerous for one person. Symptoms, laboratory results and the patient’s treatment goals must be reviewed together.
Older adults with several illnesses face a predictable rise in complexity, not a personal failure to manage care. A single prescriber or pharmacist who can see the whole regimen may catch problems that remain invisible when each specialist sees only one condition. The new findings put numbers behind that need for coordinated review.
Timing provides another useful clue. A symptom that begins after a new prescription, dose increase or hospital discharge deserves review, especially when several clinicians changed the regimen close together. A written timeline can connect the onset with laboratory changes, missed doses and known effects rather than assuming every new problem comes from the underlying diseases.
That review may also identify treatment cascades, in which a side effect is mistaken for a new illness and another medicine is added. Recognizing the original cause can simplify the regimen without abandoning necessary care.
This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.
More from Morning Overview
